VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 43 filers reported holding VERONA PHARMA PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,074,190 | -87.1% | 381,939 | -87.8% | 1.14% | -89.5% |
| Q1 2023 | $62,798,774 | -16.4% | 3,127,429 | +8.8% | 10.80% | -9.4% |
| Q4 2022 | $75,137,494 | +174.4% | 2,875,526 | +7.3% | 11.92% | +147.7% |
| Q3 2022 | $27,379,000 | +605.3% | 2,678,982 | +189.1% | 4.81% | +442.0% |
| Q2 2022 | $3,882,000 | -16.0% | 926,602 | 0.0% | 0.89% | -18.8% |
| Q1 2022 | $4,624,000 | -25.7% | 926,602 | 0.0% | 1.09% | -46.8% |
| Q4 2021 | $6,227,000 | +22.6% | 926,602 | 0.0% | 2.05% | +11.2% |
| Q3 2021 | $5,078,000 | +825.0% | 926,602 | +1003.8% | 1.85% | +717.3% |
| Q2 2021 | $549,000 | -21.8% | 83,944 | 0.0% | 0.23% | -23.6% |
| Q1 2021 | $702,000 | +0.3% | 83,944 | -16.1% | 0.30% | +18.4% |
| Q4 2020 | $700,000 | +12.2% | 100,000 | 0.0% | 0.25% | -5.3% |
| Q3 2020 | $624,000 | – | 100,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |